Medical Devices

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

Strata Critical Medical acquires Ohio Valley Perfusion Associates, a strategic move to consolidate the fragmented perfusion market and boost lifesaving care.

Mount Sinai adopts Echo IQ's AI to improve detection of aortic stenosis, a deadly but often-missed heart condition, heralding a new era for cardiac care.

Once a photography giant, Fujifilm's pivot to healthcare and tech has earned it a top spot on TIME's Most Influential list. Here’s the story of its rebirth.

A Colorado clinic is adopting FDA-cleared magnetic pulse technology to treat depression, reflecting a growing demand for non-drug mental health solutions.

A new platform from wealth firm Earned aims to close the critical financial knowledge gap for doctors burdened by debt and complex financial decisions.

A new peer-reviewed study shows Glucotrack's fully implantable glucose monitor is accurate for 240 days, a key step towards a 3-year, no-wearable future.

Medtech titan Brad Saar joins Sonablate's board, signaling a major push to make non-invasive HIFU a global standard for prostate cancer treatment.

A new study shows high success for VVT Med's ScleroSafe varicose vein treatment, but a closer look reveals the need for more long-term data.

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

Wellspect HealthCare's new Surity™ catheter targets a growing market, offering a non-invasive solution designed for comfort, discretion, and dignity.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

A new purpose-built CPAP battery uses safer, longer-lasting tech to deliver uninterrupted sleep, whether at home, camping, or during a power outage.

With double-digit growth and key US acquisitions, ESTEVE is rapidly expanding. But it's the firm's B Corp status that may redefine success in pharma.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

Benchmark Electronics raises its 2026 forecast after strong Q1 results, driven by sector growth and a successful two-year strategic transformation.

The closure of a renowned NYC eye care provider creates an unprecedented opportunity to acquire its high-tech surgical equipment at a major online auction.